Skip to main content
. 2025 Nov 23;17(1):1. doi: 10.1007/s13340-025-00852-8

Fig. 3.

Fig. 3

Associations of duration of hyperglycemic symptoms with plasma glucagon levels (upper panel), serum C-peptide immunoreactivity (CPR) (middle panel) and serum CPR/glucose ratio (lower panel) in type 1 diabetes mellitus in the DK/DKA group. X axis denotes duration of hyperglycemic symptoms (days). Serum CPR/glucose ratio is shown as calculated values multiplied by 100